racehlcbm's blog

Creative BioMart, a leading provider of innovative life science products and services, is pleased to announce the launch of its Protein-Lipids-Nucleic Acid Interaction Assay and Screening services. These new offerings provide researchers with a comprehensive solution for studying the interactions between proteins, lipids, and nucleic acids, enabling a deeper understanding of cellular processes and disease mechanisms.


Protein-lipid and protein-nucleic acid interactions play crucial roles in various biological processes, including signal transduction, gene expression, and membrane trafficking. Dysregulation of these interactions has been implicated in numerous diseases, making them attractive targets for therapeutic intervention. However, studying these interactions can be challenging due to their complex nature and the lack of reliable and efficient assay methods.


Creative BioMart's Protein-Lipids-Nucleic Acid Interaction Assay and Screening services address these challenges by offering a range of high-quality assays and screening platforms. The services are designed to provide researchers with accurate and reliable data, allowing them to gain insights into the molecular mechanisms underlying these interactions.


Key features of Creative BioMart's Protein-Lipids-Nucleic Acid Interaction Assay and Screening services include:


Comprehensive Assay Portfolio

Creative BioMart offers a wide range of assays to study protein-lipid and protein-nucleic acid interaction, including cross-linking immunoprecipitation (CLIP), surface plasmon resonance (SPR) assays, fat western, and electrophoretic mobility shift assays (EMSA). These assays can be customized to meet specific research needs and are suitable for both qualitative and quantitative analysis.


High-Throughput Screening

Creative BioMart's screening platforms enable the rapid and efficient screening of large compound libraries to identify potential modulators of protein-lipid and protein-nucleic acid interactions. The screening services can be tailored to target specific interactions or disease-related pathways, accelerating the drug discovery process.


Expert Consultation and Support

Creative BioMart's team of experienced scientists provides expert consultation and support throughout the assay and screening process. They work closely with researchers to design customized experiments, optimize assay conditions, and interpret the results, ensuring the highest quality data and reliable conclusions.


"We are excited to launch our Protein-Lipids-Nucleic Acid Interaction Assay and Screening services," said Linna, the chief marketing staff at Creative BioMart. "These services will empower researchers to unravel the complexities of protein-lipid and protein-nucleic acid interactions, leading to a better understanding of disease mechanisms and the development of novel therapeutics."


For more information about Creative BioMart's Protein-Lipids-Nucleic Acid Interaction Assay and Screening services, please visit https://www.creativebiomart.net/protein-lipids-nucleic-acid-interaction-assay-and-screening.htm.




The human body is a complex network of genes and proteins, each playing a crucial role in maintaining our health. One such gene, DNM1L, has garnered significant attention in recent years due to its vital functions and its association with various diseases. In this blog post, we will delve into the world of DNM1L, exploring its function, the diseases it is linked to, and the inheritance patterns of gene mutations. By understanding the intricacies of DNM1L, we can gain valuable insights into the mechanisms underlying these diseases and potentially pave the way for future therapeutic interventions.


Function of DNM1L

DNM1L, also known as dynamin-related protein 1, is a gene that encodes a protein involved in mitochondrial fission. Mitochondria, often referred to as the powerhouses of the cell, are responsible for generating energy in the form of adenosine triphosphate (ATP). Maintaining a healthy balance between mitochondrial fusion and fission is crucial for cellular homeostasis and proper functioning.


DNM1L plays a pivotal role in the process of mitochondrial fission, which involves the division of mitochondria into smaller units. This process is essential for various cellular functions, including cell division, apoptosis (programmed cell death), and quality control of mitochondria. DNM1L acts as a molecular scissor, facilitating the constriction and subsequent division of mitochondria.


Disease Associated with DNM1L

While DNM1L is crucial for normal cellular function, mutations in this gene can lead to various diseases. One such disease is Charcot-Marie-Tooth disease type 2A (CMT2A), a hereditary peripheral neuropathy characterized by progressive muscle weakness and sensory loss. CMT2A is caused by mutations in the DNM1L gene, leading to impaired mitochondrial fission and subsequent dysfunction of peripheral nerves.


Another disease associated with DNM1L is optic atrophy type 5 (OPA5), a rare genetic disorder characterized by the degeneration of the optic nerve, resulting in vision loss. Mutations in DNM1L disrupt mitochondrial dynamics in retinal ganglion cells, leading to the degeneration of the optic nerve and subsequent vision impairment.


Inheritance Pattern of DNM1L Gene Mutations

The inheritance pattern of DNM1L gene mutations varies depending on the specific disease. In the case of CMT2A, the mutations in DNM1L follow an autosomal dominant pattern of inheritance. This means that an affected individual has a 50% chance of passing the mutated gene to each of their offspring. Individuals who inherit the mutated gene are at risk of developing CMT2A, while those who do not inherit the mutation will not be affected.


On the other hand, the inheritance pattern of DNM1L mutations in OPA5 is not well-established. Some studies suggest an autosomal dominant pattern, similar to CMT2A, while others propose an autosomal recessive pattern. Further research is needed to elucidate the precise inheritance pattern of DNM1L mutations in OPA5.



DNM1L plays a crucial role in mitochondrial fission, a process essential for cellular homeostasis. Mutations in the DNM1L gene have been linked to diseases such as CMT2A and OPA5, highlighting the importance of understanding the function and implications of this gene. By unraveling the intricacies of DNM1L, researchers can gain valuable insights into the underlying mechanisms of these diseases and potentially develop targeted therapies. Further studies are needed to explore the precise inheritance patterns of DNM1L mutations in different diseases, paving the way for improved diagnosis and management of these conditions.